Damora Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Damora Therapeutics Inc 's ROA in the second quarter of 2026?
Damora Therapeutics Inc recorded a cumulative net loss of $-62 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -18.38%.

However, within the Healthcare sector Damora Therapeutics Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	3882.45 %	3384.82 %	1420.31 %	-53.8 %	-49.73 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-62	-34	-9	-16	-17
Return On Assets (TTM)	-18.38 %	-16.75 %	-12.13 %	-111.33 %	-95.6 %
DMRA's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	545	535	260	11	14
Seq. Total Assets Change	1.83 %	105.58 %	2326.03 %	-21.58 %	-10.89 %
Seq. Net Income Change	-	-	-	-	-

DMRA's 5 Years Annual ROA >> Back to DMRA Management Effectiveness >> Compare DMRA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Damora Therapeutics Inc 's Assets	$ 545 million	DMRA's Balance sheet
Damora Therapeutics Inc 's Income	$ -31 million	Quarterly DMRA's Income Statement
DMRA's Income by Division		See DMRA's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	1420.31 %	-55.18 %	-49.1 %	-38.55 %	-28.65 %
Total Assets in million	260	17	38	75	122
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-210	-21	-38	-62	-52
Annual Return On Assets	-80.57 %	-125.14 %	-100.32 %	-82.06 %	-42.35 %

DMRA's 5 Years Annual ROA >> Back to DMRA Management Effectiveness >> Compare DMRA ROA to its Competitors

More Return On Assets Ratios
DMRA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DMRA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DMRA's Competitors
Subscribers only: Roa for Damora Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for DMRA's Customers

You may also want to know
DMRA's Roi	DMRA's Inventory Turnover Ratio	DMRA's Growth Rates	DMRA's Dividend Comparisons
	DMRA's Profitability Ratios	DMRA's Asset Turnover Ratio	DMRA's Dividend Growth
DMRA's Roe	DMRA's Valuation Ratios	DMRA's Financial Strength Ratios	DMRA's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-13T08:19:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.